ATE360437T1 - Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a - Google Patents
Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie aInfo
- Publication number
- ATE360437T1 ATE360437T1 AT01992584T AT01992584T ATE360437T1 AT E360437 T1 ATE360437 T1 AT E360437T1 AT 01992584 T AT01992584 T AT 01992584T AT 01992584 T AT01992584 T AT 01992584T AT E360437 T1 ATE360437 T1 AT E360437T1
- Authority
- AT
- Austria
- Prior art keywords
- hemophilia
- factor xiii
- treatment
- blood clotting
- clotting factor
- Prior art date
Links
- 208000009292 Hemophilia A Diseases 0.000 title abstract 3
- 229940012444 factor xiii Drugs 0.000 title abstract 3
- 208000031220 Hemophilia Diseases 0.000 title 1
- 239000003114 blood coagulation factor Substances 0.000 title 1
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 2
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 2
- 108010071289 Factor XIII Proteins 0.000 abstract 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 2
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 abstract 1
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 abstract 1
- 229960004281 desmopressin Drugs 0.000 abstract 1
- 229960000301 factor viii Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24575100P | 2000-11-03 | 2000-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360437T1 true ATE360437T1 (de) | 2007-05-15 |
Family
ID=22927935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01992584T ATE360437T1 (de) | 2000-11-03 | 2001-11-05 | Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1337267B1 (de) |
| JP (1) | JP2004512374A (de) |
| AT (1) | ATE360437T1 (de) |
| AU (1) | AU2002225994A1 (de) |
| CA (1) | CA2427535A1 (de) |
| DE (1) | DE60128130T2 (de) |
| ES (1) | ES2282319T3 (de) |
| WO (1) | WO2002036155A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008510476A (ja) | 2004-08-27 | 2008-04-10 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製 |
| ES2378777T3 (es) | 2004-11-23 | 2012-04-17 | Zymogenetics, Inc. | Purificación del factor XIII humano recombinante |
| CN105925545A (zh) | 2008-04-21 | 2016-09-07 | 诺沃—诺迪斯克保健股份有限公司 | 干燥转谷氨酰胺酶组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE121776T1 (de) * | 1986-09-19 | 1995-05-15 | Zymogenetics Inc | Expression des biologisch aktiven faktors xiii. |
| AU2423988A (en) * | 1987-08-17 | 1989-03-09 | Liposome Company, Inc., The | A sponge enzyme having transglutaminase-like activity |
| ATE452643T1 (de) * | 1998-11-06 | 2010-01-15 | Sertoli Technologies Inc | Herstellung eines biologischen faktors und schaffung einer immunologisch vorteilhaften umgebung unter verwendung genetisch veränderter sertolizellen |
| CZ20023667A3 (cs) * | 2000-05-10 | 2003-04-16 | Novo Nordisk A/S | Farmaceutický prostředek obsahující VIIA a XIII faktory |
-
2001
- 2001-11-05 AT AT01992584T patent/ATE360437T1/de not_active IP Right Cessation
- 2001-11-05 ES ES01992584T patent/ES2282319T3/es not_active Expired - Lifetime
- 2001-11-05 WO PCT/US2001/047073 patent/WO2002036155A1/en not_active Ceased
- 2001-11-05 DE DE60128130T patent/DE60128130T2/de not_active Expired - Lifetime
- 2001-11-05 JP JP2002538964A patent/JP2004512374A/ja active Pending
- 2001-11-05 EP EP01992584A patent/EP1337267B1/de not_active Expired - Lifetime
- 2001-11-05 CA CA002427535A patent/CA2427535A1/en not_active Abandoned
- 2001-11-05 AU AU2002225994A patent/AU2002225994A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004512374A (ja) | 2004-04-22 |
| WO2002036155A1 (en) | 2002-05-10 |
| DE60128130T2 (de) | 2007-12-27 |
| CA2427535A1 (en) | 2002-05-10 |
| EP1337267A1 (de) | 2003-08-27 |
| ES2282319T3 (es) | 2007-10-16 |
| EP1337267B1 (de) | 2007-04-25 |
| AU2002225994A1 (en) | 2002-05-15 |
| DE60128130D1 (de) | 2007-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| ATE304849T1 (de) | Cyanomethyl-substituierte thiazolium- und imidazolium-verbindungen und behandlung von erkrankungen im zusammenhang mit proteinalterung | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| ATE317894T1 (de) | Desinfizierendes waschen empfindlicher textilien mit persäuren | |
| SE9702860D0 (sv) | New use | |
| DE60204966D1 (de) | Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis | |
| ATE552842T1 (de) | Verwendung von plasminogen zur wundheilung | |
| DE60100625D1 (de) | Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina | |
| ATE405277T1 (de) | Substitutions-infusionflüssigkeit und zitratanticoagulation | |
| DE60137635D1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| SE9602200D0 (sv) | Wound dressing | |
| ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| DE602004023762D1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren | |
| ATE360437T1 (de) | Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE264101T1 (de) | Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| DE50103012D1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
| ATE430578T1 (de) | Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen | |
| DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
| ATE324905T1 (de) | Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall | |
| DE60129599D1 (de) | Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b | |
| ATE222501T1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
| ATE336261T1 (de) | Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |